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ABSTRACT The human leukemic cell lines HL60 and K562, were induced to differentiate
terminally by chemical agents . The isoenzyme patterns of lactate dehydrogenase (LD) in the
cells before and after differentiation were determined electrophoretically on agarose gels . In
general, treatment of the leukemic cells with inducers of differewl 'r.in resulted in a quanti-
tative shift of the isoenzyme pattern towards anodic or cathodic forms . This was correlated
with the conversion of the chemically treated cells to morphologically more normal cells, as
verified by light microscopy and/or synthesis of hemoglobin . The LID isoenzyme patterns of
the chemically differentiated cells were : (a) characteristic for the particular cell type obtained
rather than for the nature of the inducer used ; and (b) not similar to those of normally
differentiated cells of the corresponding lineage, indicating that incomplete differentiation had
occurred .
The glycolytic enzyme lactate dehydrogenase (LD), which
catalyzes the reversible conversion of pyruvate to lactate, exists
in multiple molecular forms called isoenzymes . Five LD iso-
enzymes have been demonstrated in human tissues, cells, and
serum . They are designated LD-1 to LD-5 . LD-1 is the fastest
in migrating toward the anode and LD-5 the slowest . LD
isoenzymes have been reviewed previously (7, 9) .
Alterations of LD isoenzyme patterns have been observed
during development, under changing biological conditions, and
frequently in neoplastic tissues (7, 13). In several instances,
changes in serum LD specific isoenzyme patterns correlated
well with either tumor growth or repression (12) . Thus, analysis
of LD isoenzyme patterns may be useful in determining
whether a chemotherapeutic agent affects a neoplastic tissue .
The HL60 cell line, derived from a patient with acute
promyelocytic leukemia, proliferates continuously in suspen-
sion culture and consists predominantly of promyelocytes (5) .
These cells can be induced to terminally differentiate to mor-
phologically mature granulocytes by incubation with a wide
variety of compounds, including dimethylsulfoxide (DMSO),
hexamethylene bisacetamide (HMBA), and retinoic acid (2, 3,
6) . The induced HL60 cells have many of the functional
characteristics ofnormal peripheral blood granulocytes, includ-
ing phagocytosis, complement receptors, chemotaxis, and in-
creased oxidative metabolism (16, 17) . Other differences be-
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tweenHL60 and DMSO-treatedHL60 cells have been reported
on cell surface proteins (11) and chromatin denaturation pro-
files (19) . However, it has been suggested that DMSO-differ-
entiated HL60 cells do not reach full maturity (16, 17) because
they do not contain detectable lactoferrin, a marker for specific
granules of mature granulocytes (17), and because they do not
synthesize and secrete plasminogen activator (16) .
When cultures of HL60 cells are treated with nanomolar
concentrations of 12-0-tetradecanoylphorbol-13-acetate (TPA),
>95% of the cells are converted to macrophage-like cells, as
judged by their morphology, ability to adhere and phagocytize,
and increased enzymic activities typical of macrophages (23,
28) .
The human leukemic cell line, K562, derived from a patient
with chronic myelogenous leukemia (15), has been shown
recently to express the fetal i antigen (10) and synthesize
glycophorin A (14), a sialoglycoprotein present on erythrocyte
precursors and mature red cells . Furthermore, upon induction
with sodium butyrate or hemin, K562 cells synthesized hemo-
globin (1, 24), the type of which depends on the chemical used
to induce synthesis (4) . However, the presence of myeloid
markers on K562 cells (8) has raised the possibility that these
cells can also differentiate along other than erythroid lineages,
and it has been observed that treatment of K562 cells with
phorbol diesters can induce partial differentiation to myelo-
THE JOURNAL OF CELL BIOLOGY " VOLUME 90 AUGUST 1981 396-401
© The Rockefeller University Press - 0021-9525/81/08/0396/06 $1.00monocytic cells (reported in reference 4). Treatment ofcultures
of K562 cells with nanomolar concentrations ofTPA converted
a portion of the cells to strongly attached cells, which, in
contrast to control (untreated) cells, were characterized by a
larger number but smaller size of well defined mitochondria;
disorganized endoplasmic reticulum; cytoplasmic vacuoliza-
tion; increased ability to phagocytize latex-beads, and specific
changes in the gel electrophoretic profiles of chromosomal
proteins (P. Pantazis and J. Dahlberg; and P. Pantazis and W.
M. Bonner, unpublished data).
In this study HL60 cells were converted to granulocyte-like
or macrophage-like cells, whereas, K562 cells were converted
to hemoglobin-synthesizing or adherent cells by various in-
ducers of differentiation. The LD isoenzyme patterns of the
chemically treated cells were compared with those of the
untreated cells. Differences were observed in the patterns of
each cell type. In addition, the inducer used seemed to affect
the LD pattern observed.
MATERIALS AND METHODS
Chemicals
Sterile DMSO solution (15% DMSO, lot No. 96674) in Eagle's basal medium
was obtained from Microbiological Associates (Walkerville, Md.). HMBA was a
gilt from Dr. W. M. Bonner. HMBA, made 100 mM in RPMI 1640 medium,
filtered and stored at -20°C, wasused as a stock solution. TPA(P-Lbiochemicals,
Milwaukee, Wis.) was made 500 mM in acetone and stored at -20°C. Micro-
quantities of stock TPA solution were diluted with sterile RPMI 1640 medium
before addition to the cultures. Stock solution of 1 Msodium butyrate, pH 7, was
made from concentrated butyric acid (Fisher Scientific Co., Fair Lawn, N. J.),
neutralized with concentrated NaOH, and filtered. Benzidine dihydrochloride
(Sigma Chemical Co., St. Louis, Mo.), glacial acetic acid (Fisher), and hydrogen
peroxide (30% H2O2: Fisher) were freshly mixed before use for the benzidine
reaction. Giemsa and methylene blue staining solutions were from Harleco,
American Hospital Supply Corp., Gibbstown, N. J.
Cells and Cultures
HL60 and K562 cells were provided by Drs. R. C. Gallo and S. J. Collins.
Thecells were grown in a 5% humid incubator in RPMI 1640 medium (National
Institutes of Health Media Unit, Bethesda, Md.) and supplemented with 10%
fetal calf serum (Flow Laboratories, McLean, Va.). Cells were seeded every 4-5
dat an initial concentration of2 x 105 cells/ml in Corning T-25 flasks (Corning,
N. Y.). Differentiation of HL60 cells to granulocytes was done in the presence of
DMSO, HMBA, and retinoic acid, whereas differentiation to macrophage-like
cells was accomplished with TPA. Similarly, cultures of K562 cells treated with
sodium butyrate and TPA were converted to hemoglobin-synthesizing and at-
tached cells, respectively. The treatment periods as well as the concentrations of
chemicals used for the treatment of HL60 and K562 cells are presented in Table
I.
Whole blood from a normal donor was centrifuged to pellet the cells which
were then washed five times in phosphate buffered saline (PBS, pH 7.2). This
cell pellet, comprised mainly of erythrocytes, was used to determine the LD
isoenzyme pattern. Contamination with cells other than erythrocytes was negli-
gible and therefore ignored. To obtain granulocytes or monocytes, whole blood
was mixed with 5 vol of 0.83% NH,CI and cells were pelleted at low speed. This
step was repeatedtwiceso that only a small numberofcontaminating erythrocytes
were observed in the remaining cell population, which consisted mainly of
lymphocytes and granulocytes. Separation of these two populations was accom-
plished by centrifugation in a Ficoll-hypaque solution. More than 85% of the
pelleted cells were granulocytes. Monocytes were obtained as described by Stobo
(27).
Viability and Differentiation Tests
The viability of untreated and chemically treated HL60 and K562 cells was
determined by the trypan blue dye exclusion method. Differential counts of
control and HL60 cells treated with DMSO, HMBA, and retinoic acid were
estimated onmicroscopeslides prepared witha Shanon-Elliot Cytospin centrifuge
(Surrey, England) and stained with Giemsa's or methylene blue. Thepercentage
of spontaneously induced (control) and butyrate-induced K562 cells which
synthesized hemoglobin was calculated using a hemacytometer, according to the
benzidine method of Orkin et al. (19), as modified by Scher and Friend (25). A
minimum of 300 cells were scored for each experiment. TPA-treated flasks of
HL60 and K562 cells were rinsed four times with RPMI 1640 to remove loosely
attached cells. Stronglyattached cellswere removed bytrypsinization and counted
in a Coulter Counter, model B(Coulter Electronics, Hilea, Fla.). For photogra-
phy, TPA-attached cells were rinsed vigorously with PBS before fixation and
stained on the flask with Giemsa's or methylene blue.
Gel Electrophoresis of LD Isoenzymes
Aliquots of cell suspensions containing I x 105 cells were centrifuged to a
pellet and the supernate was discarded. Subsequently, the cells were washed once
in PBS and suspended in PBS diluted with distilled water (l :l). The cell
suspension was subjected to one cycle of freezing and thawing which caused lysis
of the cells. Thecell fragments were then separated by centrifugation. Four-,ul
samples from the clarified supernate were electrophoresed on agarose gels
according to aprocedure for the quantitative determination of LD isoenzymes
(20), as recently modified (21). Briefly, the main features ofthe procedure are (a)
an electrophretic separation of LD isoenzymes on microscopeslidescovered with
agarose-gel, (b) a colorimetric demonstration of the enzymatic activity by a
tetrazolium reduction procedure, and (c) a quantitation of the isoenzyme zones
by densitometric scanning. A Joyce-Loebl densitometer (Chromoscan model;
Joyce-Loebl Ltd., Team Valley, Gateshead, England) equipped withan integrator
was used for estimation of the percentage distribution ofLD isoenzymes.
RESULTS
Cytotoxic Effect of Inducers of Differentiation
Viability of HL60, DMSO- and HMBA-treated HL60, K562,
and butyrate-treated K562 cells remained consistently >96%,
as determined by the trypan blue method, for the periods of
treatment shown in Table I. Retinoic acid had a more cytotoxic
effect on HL60 cells with -70-75% viable cells in the culture
at the fourth d of treatment. However, retinoic acid was the
most potent inducer of myeloid differentiation (Table I), in
agreement with a previous report (2). It seemed that the more
potent the inducer of differentiation the higher its cytotoxic
TABLE I
Treatment of Leukemic Cells (HL60, K562) with Various Inducers of Differentiation and Results of Differentiation
* Determined by light microscopy of cells stained with Giemsa's or methylene blue, with the exception of K562 cells which after treatment with sodium butyrate
were assayed by the benzidine method .
Numbers in parentheses indicate percentage of spontaneously differentiated cells in untreated (control) cultures.
§ Percentages of adherent cells were calculated from flasks which were washed four times with medium before trypsinization.
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Cells induced Inducer used
Concentration of in-
ducer used
Period of
treatment
Type of cultured
cells
Percentage of differen-
tiated cells*
mm d
H L60 DMSO 170 6 suspended 80-85 (5-15)$
H L60 HMBA 2.5 6 suspended 90-95 (5-15)
HL60 Retinoic acid 1 x 10-3 4 suspended 90-95 (5-15)
H L60 TPA 20 x 10- 4 adherent 85-90§
K562 Sodium butyrate 1-2 5 suspended 65-75
K562 TPA 20 x 10-s 4 adherent 8-10effect on treated cells. TPA had no cytotoxic effect on cells
because the viability of treated cells was consistently >97%, for
TPA concentrations between 2 and 20 nM. Higher concentra-
tions of TPA in the cultures resulted in a decrease of viability
of both HL60 and K562 cells (unpublished observations). In
this study, HL60 and K562 cellswere treated with 20 nM TPA
for 4 d. Treatment of the cells with TPA for >4 d resulted in
an increasing detachment of attached cells. This was not due
to the deaths of attached cells per se because the percentage of
viable cellsin suspension remained unaltered up to 6 d. Perhaps
prolonged TPA-treatment resulted in a loss of ability of cells
to adhere.
Ability of Inducers to Induce Differentiation
Treatment of HL60 and K562 cells with inducers of differ-
entiation converted these cells into more differentiated cells
(Fig. 1). Treatment of HL60 cells with DMSO resulted in the
appearanceofgranulocytes in the cultures (Fig. I, A and B), as
was first observed by Collins et al. (6). The capability of each
inducer to produce differentiated cells is shown by the per-
centage of differentiated cells which appeared after each treat-
ment (Table I). The effectiveness of each inducer to form
granulocytes was concomitant with its ability to decrease pro-
liferation of the cells (data not shown). The ability of each
inducer to convert HL60 cells to various percentages of the
granulocytic cell types has been reported (2). Treatment of
HL60 cells with TPA converted >90% of the cellsinto attached
cells by day 4 (Fig. 1 C), in agreement with a previous report
(24). The growth rate of the HL60 cells in the culture upon
addition of TPA was zero, because the number of cells at the
time of TPA addition was not altered after incubation of the
cells in the presence ofTPA. Similar results have already been
reported (22).
2-4% of the control K562 cells in the culture were positively
stained with benzidine by day 6. However, the number of
benzidine positivelystained K562 cells was ^"70% when sodium
butyrate was present in the cultures for 6 d. Despite the fact
that a large number of butyrate-treated K562 cells synthesized
hemoglobin, we were not able to detect morphological changes
by light miscroscopy (Fig. 1 D and E) as were seen by Anders-
son et al. (1), in confirmation of a recent report that various
sublines derived from the original K562 cells, when treated
with butyrate, are induced to synthesize hemoglobin, although
they do not exhibit morphological changes (4). However, na-
nomolar concentrations of TPA in cultures of K562 cells
resulted in the appearance of -10% strongly attached cells
(Fig. I F), which possessed some morphological, functional,
and biochemical properties different from those acquired by
control K562 cells (P. Pantazis and J. Dahlberg; and P. Pantazis
and W. M. Bonner, unpublished data).
Isoenzymes of Lactate Dehydrogenase
The electrophoretic patterns of LD isoenzymes from control
and chemically treated HL60 and K562 cells are shown in Fig.
2. Note that the electrophoretic method used provided a clear
resolution of the isoenzymes. In most cases, changes could be
detected by direct observation. However, densitometric scan-
ning of these patterns allowed quantitation of the isoenzymes.
Each cell line, untreated or treated, was assayed two to four
times, in individual experiments. The standard deviation was
nearly zero for LD-I and LD-5, and <2% for LD-2, LD-3, and
LD-4. The quantitative results are shown in Table II. They
were observed in early passages of HL60 cells. In general,
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untreated (control) HL60 cells exhibited low activities of the
parental forms LD-1 and LD-5, and high activities of LD-2
and LD-3 isoenzymes. DMSO-treated cells exhibited a clear-
cut quantitative shift in the isoenzymes towards the cathodic
forms. Similar shifts were observed in the relative activities of
the isoenzymes from HL60 cells treated with HMBA (Fig. 2
and Table II). However, retinoic acid resulted in only a slight
shift ofthe LD isoenzymes towards cathodic forms, unlike the
shifts observed when HL60 cells were treated with DMSO or
HMBA. This was surprising, because retinoic acid is the most
potent inducer of HL60 myeloid differentiation (2). Perhaps
the zymogram of HL60 cells treated with retinoic acid does not
reflect the actual pattern in differentiated cells, because 25-
30°l0 ofthe treated cells were dead due to the high cytotoxicity
at the concentrations used. Variations in the relative activities
of LD-2, LD-3, and LD-4 perhaps reflect the ability of each
inducer to cause differentiation of the HL60 cells (3). It is also
likely that activity variations in the LD isoenzymes reflect
variations in the cell types obtained after treatment with each
inducer ofdifferentiation towards granulocytes (2). In general,
the ratios ofisoenzyme activitiesofuntreated and treated HL60
cells were found to be different from the ratios of isoenzymes
of fresh human granulocytes of a normal donor (Fig. 2 and
Table II).
Treatment of HL60 cells with TPA resulted in appearance
of attached cells (Fig. 1 C), as reported by others (23). The LD
isoenzyme of these cells exhibited a quantitative shift towards
the cathodic forms. This shift was associated with the morpho-
logical changes. However, the isoenzyme pattern of TPA-at-
tached HL60 cells did not resemble the pattern of normal
monocytes. This indicated that treatment of HL60 cells with
TPA shifted the isoenzyme pattern towards cathodic forms,
i.e., a pattern whch does not resemble that of normal mono-
cytes.
The ratios ofLD isoenzymesin the humanproerythroblastic
cells, K562, showed a rather Gaussian distribution with the
pattern differing from that of HL60 cells (Fig. 2). An increase
of more anodic isoenzymes was seen in hemoglobin-synthesiz-
ing cells obtained aftertreatment ofK562 cellswith millimolar
concentrations of sodium butyrate. No LD-5 was detected in
TABLE II
Quantitation of Relative Activity of LD Isoenzymes of HL60
and K562 Cells Before andAfter Treatment with Inducers of
Differentiation
Cells Treatment
Distribution
LD-1 LD-2
of LD-Isoenzymes
LD-3 LD-4 LD-5
HL60 none 11 36 41 11 1
HL60 DMSO 5 24 35 30 6
HL60 HMBA 4 21 46 25 4
HL60 Retinoic acid 6 32 42 16 4
granulocytes none 2 9 22 29 38
(normal)
HL60 TPA 3 18 38 32 10
K562 none 6 23 33 28 10
K562 Sodium bu- 27 35 32 6 0
tyrate
K562 TPA 6 24 36 27 7
erythrocytes none 44 46 10 0 0
(normal)
monocytes none 8 33 43 16 0
(normal)these cells . However, no significant changes were observed in
the pattern of attached K562 cells after TPA treatment (Fig.
1 f) . This indicated that although TPA-attached cellsandTPA-
attached HL60 cells were morphologically similar, they did not
exhibit similar LD zymograms .
DISCUSSION
The human promyelocytic and proerythroblastic cells, HL60
and K562, respectively, have been reported to be converted
into more mature cells in the presence of various inducers of
FIGURE 1
￿
Morphology of HL60 and K562 cells before and after treatment with inducers of differentiation . A, untreated HL60 cells;
B, DMSO-treated HL60 cells ; C, TPA-treated HL60 cells; D, untreated K562 cells; E, K562 cells treated with sodium butyrate ; and F,
TPA-treated K562 cells . x1,220 .
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Agarose gel electrophoretic patterns of LID isoenzymes of HL60 and K562 cells treated with various chemical agents .
Granulocytes, erythrocytes, and monocyteswere prepared from normal donors in individual experiments . Ret . Acid, retinoic acid .
differentiation (2, 3, 6, 23) . This maturation is associated with
changes in the morphological (3, 6, 23) and functional (2, 3, 6,
17, 22, 28) properties of these cells. In this study we attempted
to correlate shifts in the electrophoretic patterns ofLD isoen-
zymes with the differentiation stage as well as with the cell type
obtained after treatment ofHL60 and K562 cells with various
inducers of differentiation .
Conversion of HL60 cells to more mature cells along the
granulocyte pathway has been shown to be accompanied by
increased glucose oxidation (16) and production of superoxide
anions (2, 3, 16, 17) . In this study we showed that conversion
of HL60 promyelocytes to metamyelocytes and granulocytes
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was accompanied by a shift in the proportions of LD isoen-
zymes towards more cathodic isoenzymes . However, the chem-
ically matured HL60 cells never acquired the quantitative
pattern of LD isoenzymes of normal granulocytes . This could
be due to one or more ofthe following reasons : (a) a population
ofHL60 cells does not overcome the blockage at the promye-
locytic stage after treatment with inducers of differentiation (2,
3, 6) ; (b) although the number ofconverted HL60 cells is>80%
for all inducers used, only a small fraction of the converted
population resembles mature granulocytes (2) ; and (c) despite
their morphological assessment, the "mature" HL60 cells do
not acquire all the properties of mature normal granulocytes(16, 17). Additionally, microvariations in the LD isoenzyme
patterns ofthe converted HL60 cells reflect the ability of each
chemical agent to induce differentiation and/or variation in
the number of cell types along the granulocytic pathway (2).
It has been reported recently that TPA-treated HL60 cells
develop several of the morphological, biochemical, and func-
tional properties of normal macrophages (23). Additionally, in
our study we found that when HL60 cells were converted to
macrophagelike cells in the presence of TPA there was an
increase in the cathodic LD isoenzymes. However, this isoen-
zyme pattern was different than the pattern of normal mono-
cytes.
Treatment of the proerythroblast-like cells, K562, with so-
dium butyrate resulted in the appearance of a high percentage
of hemoglobin-synthesizing cells (1, 4). This conversion was
accompanied by an increase of the anodic isoenzymes LD-1,
LD-2, and LD-3. Also, these isoenzymes were found to be the
predominant forms of normal erythrocytes, in agreement with
a previous report (26). Thus, butyrate-treated K562 cells are
similar to normal erythrocytes with respect to the ability to
synthesize hemoglobin and lactate dehydrogenase.
Treatment ofK562 cells with TPA resulted in the appearance
of a small number of attached cells whose zymogram was
similar to that of the untreated cells but different from the
zymogram of the macrophagelike cells obtained aftertreatment
of HL60 cells with TPA. This is an indication that from
enzymatic viewpoint adherent cells derived from TPA-treated
K562 cells are different than macrophagelike cells derived from
TPA-treated HL60 cells.
The results of this study showed that changes in the differ-
entiation stage of leukemic cells in vitro were generally accom-
panied by shifts in the electrophoretic patterns of LD isoen-
zymes of these cells. As a result, the extent ofcell differentiation
could be monitored by measuring the quantitative shifts of the
enzyme. Also, the results showed that this methodology may
be useful for monitoring the effects of therapeutic agents on
biological properties rather than on cell phenotype. Using this
methodology, we are currently studying changes in the LD
isoenzyme patterns ofleukemic patients at various stages ofthe
disease before or after treatment with antileukemic agents.
We thank Mrs. 1. E. Clark for growing the cells used in this study.
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